AIs Have Similar CVD Risk to Tamoxifen in Postmenopausal HR-positive Breast Cancer
Women with breast cancer who were using aromatase inhibitors had no more increased risk for serious cardiovascular events than did women taking tamoxifen.
Women with breast cancer who were using aromatase inhibitors had no more increased risk for serious cardiovascular events than did women taking tamoxifen.
ASCO and ACS create joint guideline for survivorship care in patients with breast cancer.
Participation in a mindfulness-based stress reduction (MBSR) program yields robust and sustained improvement in cancer-related cognitive impairment.
Certain characteristics may indicate a higher risk of developing leukemia after chemotherapy and/or radiation for breast cancer survivors.
A personalized testing method may quickly and more accurately predict the effectiveness of a treatment for multiple myeloma in individual patients.
Women with a certain type of lung nodule visible on lung cancer screening CT scans face a higher risk of lung cancer than men with similar nodules.
Researchers identified a biomarker that detects the most common type of lung cancer in its earliest stage.
Patients younger than 50 years with NSCLC were more likely to have a targetable genomic alteration for which therapies exist.
Initial findings from the CLL12 trial on the use of ibrutinib in the treatment of chronic lymphocytic leukemia (CLL) in asymptomatic patients.
When blocking STAT5 in conjunction with exposure to a regular anti-cancer treatment, leukemia cells were more effectively targeted.